- Partnership with HealthyWomen and actor, mother and business
owner Nicole Ari Parker encourages
people to get informed about the importance of COVID vaccination
and vaccine options
- The Choose to Protect survey, conducted by The
Harris Poll, found 85% of U.S. adults aged 45+ agree it is
important to have a range of COVID vaccine options for themselves
and their family1
- Only two in five survey respondents say they are highly
knowledgeable about the science behind different types of COVID
vaccines1
GAITHERSBURG, Md., Oct. 10,
2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a
global company advancing protein-based vaccines with its novel
Matrix-M™ adjuvant, today announced it has joined forces with
HealthyWomen and actor, mother and business owner Nicole Ari Parker to launch Choose to
Protect™, a campaign to educate the public about the importance
of COVID vaccination and the different types of COVID vaccines.
COVID is now the fourth leading cause of death in the
U.S.2
"As a wife, mother and daughter of parents in their 80s, I feel
great responsibility to be informed, talk with our doctors and
ensure the whole family is up to date on vaccinations, particularly
given how easily COVID spread through our households last year,"
said Nicole Ari Parker. "I hope that
others will join me in choosing to protect ourselves and our loved
ones this season so that we can all feel protected as we go to
work, spend time with family and friends, and go about our everyday
lives."
To inform the campaign, Novavax, in partnership with
HealthyWomen, commissioned a survey, conducted by The Harris Poll,
among vaccinated U.S. adults aged 45+ who play a key role in
household healthcare decisions to better understand perceptions
about and attitudes toward COVID vaccination, as well as potential
motivations to take action on education gaps concerning COVID
vaccines. While COVID vaccine fatigue has been widely
reported,3 adults aged 45+ still recognize the value of
vaccines.1 In addition, 85% of respondents say it's
important to have a range of options for themselves and their
family for COVID vaccines.1
"Women are often the chief medical officers of their families,
especially those in the 'sandwich generation' who
are caregiving and making healthcare decisions for their
children and elderly parents," said Beth Battaglino, RN-C, Chief Executive Officer,
HealthyWomen. "COVID made that role much more difficult, but what
made it easier was having access to COVID vaccines that have
been well tested and are safe and effective at protecting our
loved ones from getting seriously ill, being hospitalized or
possibly even dying. The updated vaccines can also help
protect against new and emerging variants."
"COVID vaccine fatigue remains a major obstacle in maintaining
immunity and keeping vaccination rates high," said
Silvia Taylor, Executive Vice
President and Chief Corporate Affairs and Advocacy Officer,
Novavax. "Together with our partners, we encourage people to
recognize the importance of making a plan to help protect their
loved ones this season and have conversations with their healthcare
provider about available vaccine options."
Key results from the Choose to Protect survey
include:
While COVID vaccine fatigue has been widely
reported,3 adults aged 45+ still
recognize the value of vaccines.
- 82% of adults said vaccines are absolutely essential or very
important for maintaining health, and three quarters said vaccines
are absolutely essential or very important for their ability to
spend time with family.1
- The top three reasons people are motivated to get vaccinated
are because of new variants, increasing COVID cases or from wanting
to have a less severe case if they get COVID.1
A significant portion of adults feel a duty to get the COVID
vaccine for their loved ones and the betterment of society as a
whole.
- 86% agree that knowing their loved ones are vaccinated against
COVID puts them at ease.1
- 83% agree that helping to protect high-risk people in our
society is a key reason why they choose COVID vaccination for
themselves / their family.1
Even though there is interest in learning more about
vaccines, there are still gaps in knowledge.
- 85% agree it is important to have a range of COVID vaccine
options for themselves and their family.1
- Only approximately two in five say they are highly
knowledgeable about the science behind how different types of
vaccines help to protect against COVID.1
"Vaccination remains a critical tool to help protect against
COVID, especially for the elderly, and those with chronic
conditions associated with severe outcomes from COVID," said Dr.
Jose Torradas, Emergency Medicine
Physician. "Make a plan to discuss vaccine options with your
healthcare provider, and check if you're eligible to get other
vaccines, like the flu shot, at the same time."
To learn more about COVID vaccination and the options available,
visit www.ChoosetoProtect.com.
About the Choose to Protect™
Survey
The Choose to Protect™
survey was conducted online in the U.S. by The Harris Poll on
behalf of Novavax and HealthyWomen. The survey was conducted
September 7-14, 2023, among 1,005
adults aged 45+ who play a substantial role in healthcare decisions
for their household and have received at least the primary COVID
vaccine series. Data were weighted where necessary by age, gender,
race/ethnicity, region, education, marital status, household size,
household income and propensity to be online to bring them in line
with their actual proportions in the
population.
The sampling precision of Harris online polls is measured by
using a Bayesian credible interval. For this study, the sample
data is accurate to within + 4.5 percentage points using a 95%
confidence level. This credible interval will be wider among
subsets of the surveyed population of interest. All sample surveys
and polls, whether they use probability sampling, are subject to
other multiple sources of error which are most often not possible
to quantify or estimate, including, but not limited to coverage
error, error associated with nonresponse, error associated with
question wording and response options, and post-survey weighting
and adjustments.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by
discovering, developing and commercializing innovative vaccines to
help protect against serious infectious diseases. Novavax, a global
company based in Gaithersburg,
Md., U.S., offers a differentiated vaccine platform that
combines a recombinant protein approach, innovative nanoparticle
technology and Novavax's patented Matrix-M adjuvant to enhance the
immune response. Focused on the world's most urgent health
challenges, Novavax is currently evaluating vaccines for COVID-19,
influenza, and COVID-19 and influenza combined. Please visit
novavax.com and LinkedIn for more information.
About HealthyWomen
HealthyWomen is dedicated to
educating women ages 35 to 64 to make informed health decisions, to
advocate for themselves, and to prioritize their health and
wellness. Their website was the first to comprehensively
address women's health and wellness issues and continues to educate
women to make informed health decisions by providing objective,
fact-based information. For more than 30 years, women have turned
to HealthyWomen for answers to their most important healthcare
questions. To learn more, please visit www.HealthyWomen.org. Follow
HealthyWomen on Facebook, Twitter, Instagram and LinkedIn.
Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com
Media
Ali Chartan
240-720-7804
media@novavax.com
References
1 Novavax and The Harris Poll Survey Findings.
Initial Survey Highlights. Field Period: September 7-14, 2023.
2 Ahmad FB, Cisewski JA, Xu J, Anderson RN. Provisional
Mortality Data — United States,
2022. MMWR Morb Mortal Wkly Rep. 2023;72:488–492.
doi:10.15585/mmwr.mm7218a3.
3 Stamm TA, Partheymüller J, Mosor E, et al.
Determinants of COVID-19 vaccine fatigue. Nat Med.
2023;29(5):1164-1171. doi:10.1038/s41591-023-02282-y.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/novavax-launches-choose-to-protect-campaign-to-educate-public-about-importance-of-updated-covid-vaccination-this-fall-301952304.html
SOURCE NOVAVAX, INC